- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Shanghai Fosun Pharmaceutical Group Co Ltd (600196)
Shanghai Fosun Pharmaceutical Group Co Ltd stock price live, this page displays SS 600196 stock exchange data. View the 600196 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Shanghai Fosun Pharmaceutical Group Co Ltd real time stock price chart below.
What Is the Shanghai Fosun Pharmaceutical Group Co Ltd Stock Price Today?
The Shanghai Fosun Pharmaceutical Group Co Ltd stock price today is 26.13.
What Is the Stock Symbol for Shanghai Fosun Pharmaceutical Group Co Ltd?
The stock symbol for Shanghai Fosun Pharmaceutical Group Co Ltd is ""600196.""
What Stock Exchange Does Shanghai Fosun Pharmaceutical Group Co Ltd Trade On?
Shanghai Fosun Pharmaceutical Group Co Ltd is listed and trades on the Shanghai stock exchange.
Is Shanghai Fosun Pharmaceutical Group Co Ltd a Good Stock to Buy?
Determining whether Shanghai Fosun Pharmaceutical Group Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 600196 quote. (ISIN: CNE000000X38) - Test -{{UPSIDE_OR_DOWNSIDE}} - {{DIVIDEND_YIELD}} - {{CURRENT_YEAR}}
What Is the Shanghai Fosun Pharmaceutical Group Co Ltd Stock Price Today?
The Shanghai Fosun Pharmaceutical Group Co Ltd stock price today is 26.13.
What Is the Stock Symbol for Shanghai Fosun Pharmaceutical Group Co Ltd?
The stock symbol for Shanghai Fosun Pharmaceutical Group Co Ltd is ""600196.""
What Stock Exchange Does Shanghai Fosun Pharmaceutical Group Co Ltd Trade On?
Shanghai Fosun Pharmaceutical Group Co Ltd is listed and trades on the Shanghai stock exchange.
Is Shanghai Fosun Pharmaceutical Group Co Ltd a Good Stock to Buy?
Determining whether Shanghai Fosun Pharmaceutical Group Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 600196 quote. (ISIN: CNE000000X38) - Test -{{UPSIDE_OR_DOWNSIDE}} - {{DIVIDEND_YIELD}} - {{CURRENT_YEAR}}
26.13
+0.84(+3.32%)
Closed·
Fair Value
An estimate of a Shanghai Fosun Pharm's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
25.12
26.18
52 wk Range
22.88
33.10
600196 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Shanghai Fosun Pharm's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
25.1226.18
52 wk Range
22.8833.10
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.26%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.26%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
600196 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Shanghai Fosun Pharm's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Price Target
36.79
Upside
+40.78%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low P/E ratio relative to near-term earnings growth
- Fosun Pharma receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Fosun Pharma receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Fosun Pharm receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. engages in the pharmaceutical business in Mainland China and internationally. It operates through five segments: Pharmaceuticals, Medical Devices and Medical Diagnosis, Medical Services, Medical Distribution and Retail, and Others. The company is involved in the pharmaceutical manufacturing in the therapeutic areas of solid oncology, including tumors and hematologic malignancies, as well as immune-inflammatory disorders, metabolism and digestive systems, anti-infection, central nervous system, cardiovascular system, and APIs and intermediates. It also offers mRNA vaccines; medical aesthetic devices, such as medical aesthetic capital equipment, aesthetic dentistry, injectables, and personal care business units; mechanical ventilation devices under the Breas brand; and mobile pre-hospital care; professional in-hospital surgery and covers medical devices; and high-end surgical robots and medical consumables. In addition, the company provides diagnostics solutions comprising biochemical diagnostics, immune diagnostics, molecular diagnostics, microbiological diagnostics, pathological diagnostics, and chronic care management; and healthcare services, specialized medical treatment, online and offline medical services, and insurance services. Further, it engages in the operation of hospitals; and distribution and retail of healthcare products. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. was founded in 1994 and is based in Shanghai, China.
Compare 600196 to Peers and Sector
Metrics to compare | 600196 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship600196PeersSector | |
|---|---|---|---|---|
P/E Ratio | 19.0x | 17.9x | −0.4x | |
PEG Ratio | 0.85 | 0.43 | 0.00 | |
Price/Book | 1.3x | 1.9x | 2.6x | |
Price / LTM Sales | 1.5x | 2.2x | 3.1x | |
Upside (Analyst Target) | 33.6% | 23.3% | 57.3% | |
Fair Value Upside | Unlock | 20.4% | 8.0% | Unlock |
Analyst Ratings
6 Buy
2 Hold
0 Sell
Ratings:
8 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 36.79
(+40.78% Upside)
Earnings
Latest Release
Mar 23, 2026
EPS / Forecast
0.32 / 0.30
Revenue / Forecast
12.27B / 9.92B
People Also Watch
FAQ
What Is the Shanghai Fosun Pharm (600196) Stock Price Today?
The Shanghai Fosun Pharm stock price today is 26.13 CNY.
What Stock Exchange Does Shanghai Fosun Pharm Trade On?
Shanghai Fosun Pharm is listed and trades on the Shanghai Stock Exchange.
What Is the Stock Symbol for Shanghai Fosun Pharm?
The stock symbol for Shanghai Fosun Pharm is "600196."
What Is the Shanghai Fosun Pharm Market Cap?
As of today, Shanghai Fosun Pharm market cap is 69.02B CNY.
What Is Shanghai Fosun Pharm's Earnings Per Share (TTM)?
The Shanghai Fosun Pharm EPS (TTM) is 1.27.
When Is the Next Shanghai Fosun Pharm Earnings Date?
Shanghai Fosun Pharm will release its next earnings report on Apr 29, 2026.
From a Technical Analysis Perspective, Is 600196 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Shanghai Fosun Pharm Stock Split?
Shanghai Fosun Pharm has split 7 times.
How Many Employees Does Shanghai Fosun Pharm Have?
Shanghai Fosun Pharm has 40603 employees.
What is the current trading status of Shanghai Fosun Pharm (600196)?
As of Mar 27, 2026, Shanghai Fosun Pharm (600196) is trading at a price of 26.13 CNY, with a previous close of 25.29 CNY. The stock has fluctuated within a day range of 25.12 CNY to 26.18 CNY, while its 52-week range spans from 22.88 CNY to 33.10 CNY.
What Is Shanghai Fosun Pharm (600196) Price Target According to Analysts?
The average 12-month price target for Shanghai Fosun Pharm is 36.79 CNY, with a high estimate of 46 CNY and a low estimate of 30 CNY. 6 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +40.78% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.